Results

Total Results: 185 records

Showing results for "bmi screening".
Users also searched for: chlamydia

  1. effectivehealthcare.ahrq.gov/sites/default/files/cer-217-management-of-infertility-comments.pdf
    May 14, 2019 - The inclusion and exclusion criteria as well as the search strategy and screening steps are detailed … The authors have identified the principle modifiers including age, ovarian reserve and BMI in this … criteria, we did flag relevant articles of these types as part of the screening process. … Peer Reviewer #5 Results May want to mention difference in letrozole/clomid at different BMI (page 16 … We have added a statement regarding BMI regarding the Legro study as suggested. 90.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-management-of-infertility-comments.pdf
    May 14, 2019 - The inclusion and exclusion criteria as well as the search strategy and screening steps are detailed … The authors have identified the principle modifiers including age, ovarian reserve and BMI in this … criteria, we did flag relevant articles of these types as part of the screening process. … Peer Reviewer #5 Results May want to mention difference in letrozole/clomid at different BMI (page 16 … We have added a statement regarding BMI regarding the Legro study as suggested. 90.
  3. effectivehealthcare.ahrq.gov/products/antipsychotics-children/research-protocol
    June 04, 2010 - General adverse events include: Extrapyramidal effects Weight gain (e.g., using Body Mass Index (BMI … response, remission, relapse, speed of response, time to discontinuation of medication Growth (using BMI … arrhythmias, agranulocytosis General adverse events: extrapyramidal effects, weight gain (e.g., using BMI
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-research-report-integrating-health-system-data.pdf
    April 01, 2020 - Permanente used their own internal data to help operationalize the implementation of guidelines on screening … progression of prediabetes to type 2 diabetes (using HbA1c) across different groups (e.g., baseline HbA1c, BMI … /monitoring intervals based on one of three risk groups as opposed to universally applied screening/ … Screening for Asymptomatic Carotid Artery Stenosis: A Systematic Review and Meta- Analysis for the U.S … Screening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-table-B-1-observational-studies.xlsx
    March 20, 2021 - Children 5–12 years old Ab+ Two negative serology propensity matched (age, gender, immunodeficiency, BMI … of Trento, Italy Data obtained as part of the study Adult residents of Trento Italy with serological screening … jamainternmed.2021.2959 Italy Prospective cohort 12 General People in Italy of all ages recruited from screening … the study All ages, people in Italy with PCR testing during first infection surge, recruited from screening
  6. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
    December 04, 2015 - We will track the screening and selection results in EndNote. C.!Study!Selection! … The title/abstract screening and full-text selection processes will be conducted and documented in Endnote … BMI,!BMI!percentiles,!fat!mass,!waist!circumference! Dyslipidemia! Incidence!of!dyslipidemia,!total! … BMI!=!body!mass!index_!ECG!=!electrocardiogram_!EPS! =!extrapyramidal!symptoms_!GGT!=! … Any decisions to combine outcomes within these clusters (e.g., weight and BMI changes as an SMD) will
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
    October 05, 2018 - women with osteoporosis defined by low bone density or by the presence of vertebral fractures found on screening … Before and throughout screening, team members will meet regularly to discuss study entry criteria, the … screening process and issues as they arise to ensure consistency within and between investigators. … Agency for Healthcare Research & Quality ALP alkaline phosphatase BMD bone mineral density BMI … [2] Assessment of fracture risk and its application to screening for postmenopausal osteoporosis.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pediatric-ehr_disposition-comments.pdf
    May 01, 2015 - variable precision such as wt in kilograms or pounds and ounces; simple computed derived data such as BMI … We do include a section on obesity in GQ3, and we reference the need to include BMI for standard growth … screening. … Newborn screening, including hearing screening, is an important part of the interaction with public … We concur that newborn screening is extremely important.
  9. effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research-protocol
    April 12, 2018 - women with osteoporosis defined by low bone density or by the presence of vertebral fractures found on screening … Before and throughout screening, team members will meet regularly to discuss study entry criteria, the … screening process and issues as they arise to ensure consistency within and between investigators. … Agency for Healthcare Research & Quality ALP alkaline phosphatase BMD bone mineral density BMI … Assessment of fracture risk and its application to screening for postmenopausal osteoporosis.
  10. effectivehealthcare.ahrq.gov/products/prostatic-hyperplasia-medications/research-protocol
    April 24, 2015 - adut men (age 45 years and over) with LUTS associated with BPH (i.e. defined by comorbidities [i.e., BMI … All studies identified as relevant by either investigator will undergo full-text screening. … Two investigators will independently perform full-text screening to determine if inclusion criteria are … Differences in screening decisions will be resolved by consultation between investigators, and, if necessary … Throughout the screening process, team members will meet regularly to discuss training material and issues
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/linking-evidence-reviews-methods_0.pdf
    October 01, 2018 - The leads selected the systematic review in support of the USPSTF recommendation on screening for abnormal … this pilot, one external factor that created a “burning platform” for Kaiser Permanente’s focus on screeningScreening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008 … (vs no screening) reduced mortality, or that earlier or more intensive mgmt of CVD risk in persons … the studies), these were adults without serious or acute medical conditions, mean age 51-67, mean BMI
  12. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
    December 01, 2015 - Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call … Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born … Targeted hepatitis C screening among ex-injection drug users in the community. … Higher BMI 24-week fixed duration triple therapy with telaprevir, pegylated interferon alfa-2b, and … Higher BMI 24-week fixed duration triple therapy with telaprevir, pegylated interferon alfa-2b, and
  13. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
    December 01, 2015 - Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call … Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born … Targeted hepatitis C screening among ex-injection drug users in the community. … Higher BMI 24-week fixed duration triple therapy with telaprevir, pegylated interferon alfa-2b, and … Higher BMI 24-week fixed duration triple therapy with telaprevir, pegylated interferon alfa-2b, and
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
    June 04, 2010 - General adverse events include: • Extrapyramidal effects • Weight gain (e.g., using Body Mass Index (BMI … response, remission, relapse, speed of response, time to discontinuation of medication; • Growth (using BMI … arrhythmias, agranulocytosis; • General adverse events: extrapyramidal effects, weight gain (e.g., using BMI
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
    November 01, 2012 - phototherapy a Key Question abbreviations: ALT = alanine aminotransferase; AST = aspartate aminotransferase; BMI … anemia, neutropenia], hypertension, alteration in metabolic parameters [e.g., glucose, lipids, weight, BMI … Acronyms/Abbreviations ALT alanine aminotransferase AST aspartate aminotransferase BMI body mass
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
    January 01, 2013 - 12-week single center randomized crossover trial of n- 3s 31 participants (mean age 67.4; mean BMI … hypertriglyceridemia (TG ≥500mg/dL) mean age 52.1-53.9; approx.. 93% ≤65; 75% male~90% Caucasian; mean BMI … concentration, antioxidant enzyme activity (catalase, glutathione peroxidase, superoxide dismutase BMI … least 1 of the following risk factors: smoking, arterial hypertension, and/or overweight obesity (BMI … converting enzyme; Apo apolipoprotein; ARB angiotensin receptor blocker; AUC area under the curve; BMI
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
    January 24, 2022 - 2020 - 10/2020 Provided blood at least once after a PCR+ NR 866 Median (IQR): 42 (31-53) NR 200 (23) BMI … Cardiovascular Disease: 80,497 (4.1) Diabetes mellitus: 94,623 (4.8) Immunocompromised: 24,707 (1.2) Obesity (BMI … Cardiovascular Disease: 3136 (5.2) Diabetes mellitus: 4030 (6.7) Immunocompromised: 946 (1.6) Obesity (BMI … positive result consistent with previous infection RT-PCR plus lateral-flow assay Regular routine screening … System, who received PCR testing for symptomatic, hospitalized for any reason, required preprocedural screening
  18. effectivehealthcare.ahrq.gov/products/stroke-afib-update/research-protocol
    July 07, 2017 - with moderate to severe chronic kidney disease (CKD) [eGFR<60], valvular heart disease, extremes of BMI … Inclusion at the title and abstract screening level will be liberal; if a single reviewer believes an … Articles included by either reviewer will undergo full-text screening. … At the full-text screening stage, two independent reviewers must agree on a final inclusion/exclusion … At random intervals during screening, quality checks by senior team members will occur to ensure that
  19. Menopause Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
    March 01, 2015 - prevalence and duration of vasomotor symptoms among women depending on ethnicity and body mass index (BMI … Systematic Reviews and Meta- Analyses) diagram (Figure B) depicts the flow of search, title/abstract screening … , full-text screening, and study selection. … A total of 8,372 records were excluded in the first round of screening because, from the title and abstract … Trial arm characteristics: Participant information such as number of participants, age, ethnicity, BMI
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
    May 01, 2013 - We excluded 21,687 of these citations during title screening, and 7,008 during abstract screening. … of fixed low-dose dalteparin 5000 IU/day versus placebo among hospitalized obese patients with a BMI … We suggest that weight-based dosing compared with fixed-dosing, rather than BMI-based dosing compared … Such trials need to ensure that those at both extremes of weight the underweight (BMI < 18 kg/m2) and … severely obese (BMI > 40 kg/m2) are adequately represented in these trials.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: